Calcium Channel Blockers and the Risk of Cancer: A Preclinical Assessment

[1]  H. Jick.  Calcium-channel blockers and risk of cancer , 1997, The Lancet.

[2]  J. Olsen,et al.  Cancer risk in users of calcium channel blockers. , 1997, Hypertension.

[3]  R. Collins,et al.  Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding , 1997, Journal of Human Hypertension.

[4]  J. Barrett,et al.  Effects of alterations in calcium homeostasis on apoptosis during neoplastic progression. , 1997, Cancer research.

[5]  Morris J. Brown.  Calcium-channel blockers and cancer , 1996, The Lancet.

[6]  R. Roberts,et al.  Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. , 1996, Carcinogenesis.

[7]  H. Iishi,et al.  Inhibition by verapamil of cholecystokinin-enhancement of pancreatic carcinogenesis induced by azaserine in Wistar rats. , 1996, Cancer letters.

[8]  J. Guralnik,et al.  Do calcium channel blockers increase the risk of cancer? , 1996, American journal of hypertension.

[9]  A. Balakumaran,et al.  Calcium channel blockers induce thymic apoptosis in vivo in rats. , 1996, Toxicology and applied pharmacology.

[10]  E. Ritz,et al.  Inhibitory effect of calcium channel blockers on human mesangial cell growth: evidence for actions independent of L-type Ca2+ channels. , 1996, Kidney international.

[11]  A. Monro.  Are lifespan rodent carcinogenicity studies defensible for pharmaceutical agents? , 1996, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[12]  G. Williams,et al.  Chemical carcinogen mechanisms of action and implications for testing methodology. , 1996, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[13]  T. Loh,et al.  Roles of calcium in the regulation of apoptosis in HL-60 promyelocytic leukemia cells. , 1995, Life sciences.

[14]  V. Soldatenkov,et al.  The effect of hyperthermia and verapamil on primary and metastatic colon adenocarcinoma cell-lines - inhibition of proliferation, cell-cycle distribution and onset of apoptosis. , 1995, Oncology reports.

[15]  S. Eto,et al.  Stimulatory Effect of Interleukin‐1α on Proliferation through a Ca2+/Calmodulindependent Pathway of a Human Thyroid Carcinoma Cell Line, NIM 1 , 1995, Japanese journal of cancer research : Gann.

[16]  M. Berridge,et al.  Calcium signalling and cell proliferation , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[17]  S. Orrenius,et al.  Apoptosis: molecular mechanisms and implications for human disease , 1995, Journal of internal medicine.

[18]  F. Chisari,et al.  Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice , 1995, Hepatology.

[19]  W. Zhou,et al.  Calcium, calmodulin and cell cycle progression. , 1995, Cellular signalling.

[20]  B. Robinson.  Molecular genetics of thyroid and parathyroid neoplasia. , 1995, The Australian and New Zealand journal of surgery.

[21]  R. Jensen,et al.  In Vitro Growth Inhibition of Growth Factor-stimulated Meningioma Cells by Calcium Channel Antagonists , 1995 .

[22]  Dariusz Leszczyński,et al.  Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. , 1994, The American journal of pathology.

[23]  J. Simard,et al.  Inverse relationships between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  A. Nyska,et al.  Constipation and Megacolon in Rats Related to Treatment with Oxodipine, a Calcium Antagonist , 1994, Toxicologic pathology.

[25]  S. Orrenius,et al.  Signal transduction pathways in apoptosis. , 1994, Stem cells.

[26]  P. Nicotera,et al.  Apoptosis: molecular control point in toxicity. , 1994, Toxicology and applied pharmacology.

[27]  R. Kluck,et al.  Calcium chelators induce apoptosis--evidence that raised intracellular ionised calcium is not essential for apoptosis. , 1994, Biochimica et biophysica acta.

[28]  H C Pitot,et al.  Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis. , 1994, Carcinogenesis.

[29]  B. Hulka,et al.  Steroid hormones and risk of breast cancer , 1994, Cancer.

[30]  Y. Lee,et al.  Inhibition of cell growth and intracellular Ca2+ mobilization in human brain tumor cells by Ca2+ channel antagonists. , 1994, Molecular and chemical neuropathology.

[31]  J. Larrick,et al.  Inhibition of apoptosis as a mechanism of tumor promotion , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  M. Deltenre,et al.  Helicobacter pylori: the link with gastric cancer. , 1994, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[33]  S. Singh,et al.  Potentiation of tamoxifen activity by verapamil in a human breast cancer cell line. , 1994, Biochemical pharmacology.

[34]  B. Hogan,et al.  Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene. , 1994, Cancer research.

[35]  U. Thorgeirsson,et al.  Tumor incidence in a chemical carcinogenesis study of nonhuman primates. , 1994, Regulatory toxicology and pharmacology : RTP.

[36]  E. Kohn,et al.  Calcium-mediated signal transduction: biology, biochemistry, and therapy , 1994, Cancer and Metastasis Reviews.

[37]  C. Capen,et al.  Neoplastic Lesions of Questionable Significance to Humans , 1994, Toxicologic pathology.

[38]  E. Bomhard,et al.  Frequency of spontaneous tumours in Wistar rats in 2-year studies. , 1994, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[39]  D. Chung,et al.  Inhibitory Effect of Calcium Channel Blockers on Growth of Pancreatic Cancer Cells , 1994, Pancreas.

[40]  M. Rosin,et al.  Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients. , 1994, Mutation research.

[41]  L. Pradayrol,et al.  Inhibition of gastrin‐induced proliferation of AR4–2j cells by calcium channel antagonists , 1994, International journal of cancer.

[42]  M. Berridge.  The biology and medicine of calcium signalling , 1994, Molecular and Cellular Endocrinology.

[43]  I. Purchase.  Current Knowledge of Mechanisms of Carcinogenicity: Genotoxins versus Non-genotoxins , 1994, Human & experimental toxicology.

[44]  E. Sher,et al.  Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines. , 1993, The Journal of biological chemistry.

[45]  B. Short.  Cell proliferation and renal carcinogenesis. , 1993, Environmental health perspectives.

[46]  R. G. Croy.  Role of chemically induced cell proliferation in carcinogenesis and its use in health risk assessment. , 1993, Environmental health perspectives.

[47]  L. Tomatis.  Cell proliferation and carcinogenesis. A brief history and current view based on IARC Workshop report , 1993 .

[48]  L. Tomatis.  Cell proliferation and carcinogenesis: a brief history and current view based on an IARC workshop report. International Agency for Research on Cancer. , 1993, Environmental health perspectives.

[49]  D. Parkin,et al.  Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[50]  P. Rorsman,et al.  Increased activity of L-type Ca2+ channels exposed to serum from patients with type I diabetes. , 1993, Science.

[51]  C. Haslett,et al.  Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro. , 1993, The Journal of clinical investigation.

[52]  D. Carson,et al.  Apoptosis and disease , 1993, The Lancet.

[53]  G. Dubyak,et al.  Effect of glucocorticosteroid treatment on intracellular calcium homeostasis in mouse lymphoma cells. , 1993, Molecular endocrinology.

[54]  A. Means,et al.  Regulation of the cell cycle by calcium and calmodulin. , 1993, Endocrine reviews.

[55]  M. Piontek,et al.  Effect of calcium-modifying agents on the growth of human gastric carcinoma cells in vitro. , 1992, Anticancer research.

[56]  J. Taylor,et al.  Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse. , 1992, Cancer research.

[57]  T. Cotter,et al.  Elevations in cytosolic free Ca2+ are not required to trigger apoptosis in human leukaemia cells , 1992, Clinical and experimental immunology.

[58]  M. Collins,et al.  Inhibition of apoptosis by calcium ionophores in IL-3-dependent bone marrow cells is dependent upon production of IL-4+. , 1992, Journal of immunology.

[59]  Gwyn T. Williams.  Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.

[60]  P. Grasso,et al.  Evidence for and possible mechanisms of non-genotoxic carcinogenesis in rodent liver. , 1991, Mutation research.

[61]  W. Colucci,et al.  Calcium influx modulates DNA synthesis and proliferation in A7r5 vascular smooth muscle cells. , 1991, European Journal of Pharmacology.

[62]  J. K. Bubien,et al.  Transmembrane ion conductance in human B lymphocyte activation. , 1990, Journal of immunology.

[63]  S. Orrenius,et al.  Receptor-operated calcium influx in rat hepatocytes. Identification and characterization using manganese. , 1990, The Journal of biological chemistry.

[64]  E. Alnemri,et al.  Activation of internucleosomal DNA cleavage in human CEM lymphocytes by glucocorticoid and novobiocin. Evidence for a non-Ca2(+)-requiring mechanism(s). , 1990, The Journal of biological chemistry.

[65]  B. Ames,et al.  Too many rodent carcinogens: mitogenesis increases mutagenesis. , 1990, Science.

[66]  W. Bursch,et al.  DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. , 1990, Cancer research.

[67]  H. Iishi,et al.  Effect of calcium channel blockers on gastric carcinogenesis and caerulein enhancement of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. , 1990, Cancer research.

[68]  M. D. Hogan,et al.  The impact of toxicity on carcinogenicity studies: implications for risk assessment. , 1988, Carcinogenesis.

[69]  W. F. Schmidt,et al.  Antiproliferative effect of verapamil alone on brain tumor cells in vitro. , 1988, Cancer research.

[70]  D. Krewski,et al.  Statistical Methods in Cancer Research: Volume III: The Design and Analysis of Long-Term Animal Experiments , 1987 .

[71]  T. Okazaki,et al.  Role of intracellular calcium ion in human promyelocytic leukemia HL-60 cell differentiation. , 1986, Cancer research.

[72]  D. Handley,et al.  Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110. , 1986, The American journal of pathology.

[73]  S. Eto,et al.  Calcium dependency in the growth of adult T-cell leukemia cells in vitro. , 1986, Cancer research.

[74]  N. Colburn,et al.  Extracellular calcium requirement for promotion of transformation in JB6 cells. , 1986, Cancer research.

[75]  L. Ryan.  Efficiency of age-adjusted tests in animal carcinogenicity experiments. , 1985, Biometrics.

[76]  W. Bursch,et al.  Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. , 1984, Carcinogenesis.

[77]  Kenneth Wright,et al.  Letter to the editor , 1967, Commun. ACM.

[78]  J. Tímár,et al.  Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin αIIbβ3 and tumor-cell-induced platelet aggregation , 2005, Journal of Cancer Research and Clinical Oncology.

[79]  Ø. Bruserud,et al.  In vitro effect of r-verapamil on acute myelogenous leukemia blast cells: studies of cytokine secretion and cytokine-dependent blast proliferation , 2004, Cancer Chemotherapy and Pharmacology.

[80]  Gerald LitwackS.  Activation of Internucleosomal DNA Cleavage in Human CEM Lymphocytes by Glucocorticoid and Novobiocin , 2001 .

[81]  井口 信夫.  Stimulatory effect of interleukin-1α on proliferation through a Ca[2+]/calmodulin-dependent pathway of a human thyroid carcinoma cell line, NIM 1 , 1996 .

[82]  D. Dr.  Calcium regulation of apoptosis. , 1995 .

[83]  D. Dowd.  Calcium regulation of apoptosis. , 1995, Advances in second messenger and phosphoprotein research.

[84]  J. DiGiovanni,et al.  Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis. , 1994 .

[85]  E. Bomhard.  Frequency of spontaneous tumours in NMRI mice in 21-month studies. , 1993, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[86]  W. Bursch,et al.  Cell death by apoptosis and its protective role against disease. , 1992, Trends in pharmacological sciences.

[87]  J. Whitfield.  Calcium signals and cancer. , 1992, Critical reviews in oncogenesis.

[88]  Whitfield Jf.  Calcium signals and cancer. , 1992 .

[89]  T. Grogan,et al.  P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  Thomas E. Moritz,et al.  Chronic calcium antagonist use in carcinoma of the lung and colon: a retrospective cohort observational study. , 1990, Cancer investigation.

[91]  T. Sladek,et al.  Antimetastatic action of diltiazem on LS/BL tumor cells in liver tumor-colony assay. , 1990, Neoplasma.

[92]  J. Isaacs,et al.  Role of calcium in the programmed death of rat prostatic glandular cells , 1990, The Prostate.

[93]  M. Pawlikowski,et al.  Involvement of calcium channels in control of the pituitary tumoral cell proliferation in vitro , 1989 .

[94]  M. Benson,et al.  Calcium channel antagonists delay regression of androgen‐dependent tissues and suppress gene activity associated with cell death , 1988, The Prostate.

[95]  C. Ra,et al.  Ultrastructural effects of DDT on cells grown in vitro. , 1987 .

[96]  E. Karbe,et al.  Spontaneous tumors of 2000 Wistar TNO/W.70 rats in two-year carcinogenicity studies. , 1986, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[97]  S. Grinstein,et al.  Characterization of the role for calcium influx in mitogen‐induced triggering of human T cells. Identification of calcium‐dependent and calcium‐independent signals , 1986, European journal of immunology.

[98]  B. Klein,et al.  Early events in human B cell activation: metabolic pathways vary according to the first signal used , 1986, European journal of immunology.

[99]  T. Vanaman,et al.  Calcium and calmodulin in cell growth and transformation. , 1984, Biochimica et biophysica acta.

[100]  Bonnie F. Sloane,et al.  Calcium Channel Blockers: Inhibitors of Tumor Cell-Platelet-Endothelial Cell Interactions , 1984 .

[101]  J Wahrendorf,et al.  Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Supplement.